CEN Biotech, Inc. (CENBF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 29, 2025, 9:30 AM EDT

CEN Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2021 FY 2020 FY 2019 FY 2018 FY 2017 2013 - 2016
Period Ending
May '25 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 2013 - 2016
Market Capitalization
011----
Upgrade
Enterprise Value
-18----
Upgrade
Last Close Price
0.000.21----
Upgrade
PS Ratio
0.0117.87----
Upgrade
PB Ratio
0.00-6.76----
Upgrade
EV/Sales Ratio
-28.42----
Upgrade
Debt / Equity Ratio
-2.67-3.34-1.13-0.80-0.90-0.92
Upgrade
Asset Turnover
0.130.09----
Upgrade
Quick Ratio
0.020.040000.00
Upgrade
Current Ratio
0.030.050.00000.00
Upgrade
Return on Assets (ROA)
-10.10%-149.32%-20.28%-22.07%-23.73%-83.19%
Upgrade
Return on Capital (ROIC)
-22.70%-420.97%----
Upgrade
Earnings Yield
-47438.88%-168.72%----
Upgrade
FCF Yield
-9116.61%-3.20%----
Upgrade
Buyback Yield / Dilution
-48.69%-29.59%-24.15%-4.19%-201.08%-22.66%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.